Thanks to private funding, 100% of every dollar donated to The Lustgarten Foundation goes directly to pancreatic cancer research.

Press Releases

Read current and past press releases outlining the latest news and announcements from The Lustgarten Foundaiton.

2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018

2018 Press Releases


Lustgarten Funded Study Shows Loss of Fat and Muscle is a Common First Sign of Pancreatic Cancer

Woodbury, N.Y., June 21, 2018 - In a study published in Nature, researchers found that the breakdown of muscle tissue and adipose (fat) is an early sign of pancreatic cancer. The Lustgarten-funded research was conducted by Dr. Laura Danai and Dr. Matthew Vander Heiden from Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology, and Dr. Ana Babic and Dr. Brian Wolpin at Dana-Farber Cancer Institute. These promising findings may contribute to earlier detection of pancreatic cancer. Read More...


Genetic Sequencing of Advanced Pancreatic Cancer Enables Personalized Medicine

WOODBURY, N.Y., June 14, 2018 /PRNewswire-USNewswire/ -- In a study published today in Cancer Discovery, genomic analyses of metastatic pancreatic cancers have suggested that approximately one third of pancreatic cancer patients may have a genomic alteration that could impact treatment decisions and guide doctors to choose a specific therapy for a personalized medicine approach. This work was funded by the Lustgarten Foundation and the Hale Center for Pancreatic Cancer Research at DanaFarber Cancer Institute.. Read More...


Organoids Accurately Predict Treatment Response of Pancreatic Cancer Patients

Woodbury, NY (May 31, 2018) – Today in Cancer Discovery, an international team of researchers led by Dr. David Tuveson, Cold Spring Harbor Laboratory (CSHL) Professor and Chief Scientist of the Lustgarten Foundation, reports on results of 66 organoids derived from pancreatic ductal adenocarcinoma (PDAC) tumor specimens at various stages of the disease. The researchers demonstrated that the patient-derived organoids, which are three-dimensional hollow spheres of cells cultured from tumors, can quickly and accurately predict how patients with pancreatic cancer respond to a variety of treatments, facilitating a personalized medicine approach to the deadly disease. Read More...


Lustgarten-Funded Researcher Unlocks How Pancreatic Cancer Metastasizes to the Liver

WOODBURY, N.Y., May 17, 2018 /PRNewswire-USNewswire/ -- Lustgarten Foundation Distinguished Scholar Douglas Fearon, M.D., a professor at Cold Spring Harbor Laboratory (CSHL), has discovered how pancreatic cancer metastasizes to the liver following surgery, as reported in today's online edition of leading biomedical journal Science."This discovery is significant because for patients who undergo pancreatic cancer surgery, there is typically a period lasting up to two weeks during which T cells are depleted, owing to a surge in post-operative stress hormone (cortisol) levels," Dr. Fearon said.. Read More...


The Lustgarten Foundation and Stand Up To Cancer Launch Partnership Focused on Pancreatic Cancer

CHICAGO, April 16, 2018 /PRNewswire/ -- The Lustgarten Foundation for Pancreatic Cancer Research and Stand Up To Cancer (SU2C) announced Sunday at the Annual Meeting of the American Association for Cancer Research that they are entering into a formal strategic partnership to drive research to improve outcomes for pancreatic cancer patients. The Pancreatic Cancer Collective will accelerate research for pancreatic cancer patients who desperately need better treatments. With support from the Lustgarten Foundation and Stand Up To Cancer, the Pancreatic Cancer Collective launches with an initial commitment of $25 million. Read More...


Announcing the Pancreatic Cancer Collective An initiative of the Lustgarten Foundation and Stand Up To Cancer


CHICAGO, April 15, 2018 /PRNewswire-USNewswire/ -- The Lustgarten Foundation and Stand Up To Cancer (SU2C) announced today at the Annual Meeting of the American Association for Cancer Research, SU2C's Scientific Partner, that they are entering into a formal strategic partnership to drive research to improve outcomes for pancreatic cancer patients. The Pancreatic Cancer Collective, funded by the Lustgarten Foundation and Stand Up To Cancer, will accelerate research for pancreatic cancer patients who desperately need better treatments. The initial funding commitment will be $25 million. Read More...


Gavin DeGraw Lends His Voice To Pancreatic Cancer Research Partnering With The Lustgarten Foundation To Raise Awareness


WOODBURY, N.Y., March 28, 2018 /PRNewswire/ -- Having lost his mother to the disease, singer, songwriter Gavin DeGraw knows firsthand how devastating pancreatic cancer is for patients and their families. Gavin is turning his grief into action by helping the Lustgarten Foundation raise awareness by encouraging people to get involved with the Foundation. Experience the interactive Multichannel News ReleaseRead More...

Lustgarten Foundation Appoints Two New Board Members

WOODBURY, N.Y., March 20, 2018 /PRNewswire-USNewswire/ -- The Lustgarten Foundation announced today the appointment of two new board members – Dr. Kenneth Goodman and Ms. Willa Shalit – to its current 12-member Board of Directors. Dr. Goodman brings years of radiology and leadership experience to the role while Ms. Shalit has extensive expertise in both the for-profit and not-for-profit sectors and is the co-founder of Let's Win, an affiliate organization of the Foundation.Read More...

LUSTGARTEN FOUNDATION APPOINTS DAVID TUVESON, M.D., Ph.D., CHIEF SCIENTIST

WOODBURY, New York (March 19, 2018) — The Lustgarten Foundation announced today the appointment of David Tuveson, M.D., Ph.D., as its Chief Scientist. Dr. Tuveson is the Director of the Cold Spring Harbor Laboratory (CSHL) Cancer Center, the Roy J. Zuckerberg Professor of Cancer Research and oversees the Lustgarten Foundation’s dedicated research laboratory at Cold Spring Harbor Laboratory. He previously served as the Foundation’s Research Director.Read More...

Stand Up To Cancer Announces $11M Collaborative, Multi-disciplinary Research Program; Microsoft Will Bring Power of AI to Investigate Immune System Response to Cancers

Santa Monica, CA (January 30, 2018) — Stand Up To Cancer (SU2C) announces today a “Convergence 2.0” research initiative that awards $11 million to seven multi-disciplinary research teams to investigate immune system response to cancers. The multi-institutional teams being announced today at SU2C’s Scientific Summit draw from the nation’s top academic research centers and will have access to Microsoft Research’s experts in machine learning and artificial intelligence.Read More...

Study Shows Blood Test Can Detect 8 Types of Cancer


WOODBURY, N.Y., Jan. 18, 2018 /PRNewswire/ -- Lustgarten Foundation funded researchers at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins have designed a multi-analyte blood test that can detect the presence of pancreatic cancer as part of a panel of eight common cancers (pancreas, ovary, liver, stomach, esophagus, colorectum, lung and breast) as reported in the online edition of Science today. Read More...


Lustgarten Foundation Awarded $22 Million For Pancreatic Cancer Research


WOODBURY, N.Y., Jan. 15, 2018 /PRNewswire-USNewswire/ -- The Lustgarten Foundation announced today that it funded $22 million in 2017 as part of its commitment to invest an unprecedented $40 million by the end of 2018. In addition to funding the most accomplished scientists in pancreatic cancer research, the Foundation is attracting new researchers to the field. New to the field of pancreatic cancer research as a result of this funding are David Sabatini, M.D., Ph.D., Whitehead Institute for Biomedical Research and David Pellman, M.D., Dana-Farber Cancer Institute. Read More...

CREATIVE BATH PRODUCTS, INC. DONATES $3.9 MILLION TO THE LUSTGARTEN FOUNDATION FOR PC RESEARCH


WOODBURY, New York (Jan 10, 2018) - The Lustgarten Foundation announced today that it received nearly $4 million from Creative Bath Products, Inc. to support pancreatic cancer research. The Central Islip headquartered Creative Bath Products consists of five business units: Creative Bath Products, Inc.,Creative Ware, Creative Home Furnishings, Creative Private Label/U.S. Manufacturing and Bath Creations. The Lustgarten Foundation is the largest private funder of pancreatic cancer research. Thanks to private funding, 100 percent of every dollar donated by Creative Bath Products will go directly to research Read More...

415 Crossways Park Drive, Suite D, Woodbury, NY 11797
Toll Free: 1-866-789-1000 P: 516-737-1550 F: 516-584-6265

logos-3-

2015 website development and design sponsored by Celgene